[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100509720":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":35,"slug":7,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":7,"eligibilityCriteria":39,"healthyVolunteers":36,"sex":40,"minAge":7,"maxAge":7,"enrollmentInfo":41,"targetDuration":44,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Jinling Hospital, China","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Le Qe, M.D.","CONTACT","15720625951","septsoul@hotmail.com",[15],{"facility":16,"status":17,"city":18,"state":19,"zip":20,"country":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China","RECRUITING","Nanjing","Jiangsu","210000","China",{"type":23,"coordinates":24},"Point",[25,26],118.77778,32.06167,{"lat":26,"lon":25},[29],{"name":30,"role":11,"phone":12,"phoneExt":7,"email":13},"Le Qu, M.D.",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Le Qu","Associate chief urologist","100509720",false,"NCT05917106","Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)","Inclusion Criteria:\n\n* Newly diagnosed renal cell carcinoma\n* Without any treatment\n* Agree and accept radical surgical treatment\n* Signed written informed consent\n* ECOG(Eastern Cooperative Oncology Group) performance is 0 or 1\n* Follow up protocol and related procedures\n\nExclusion Criteria:\n\n* Had other cancers\n* Had received any antitumor therapy before\n* Known or suspected active autoimmune disease\n* Informed consent is not possible due to medical or psychiatric problems\n* Have clinical symptoms or diseases of the heart that are not well controlled\n* Patients judged by the investigators to be unsuitable for inclusion in this study","ALL",{"count":42,"type":43},450,"ESTIMATED","5 Years","OBSERVATIONAL","To conduct prospective studies to confirm the value of circulating tumor DNA and its abnormal methylation in longitudinal monitoring of patients undergoing kidney cancer surgery.",[48,49,50,51,52],"Carcinoma","Renal Cell Carcinoma","RCC","Kidney Neoplasms","Kidney Cancer","2025-12-04",{"date":55,"type":56},"2025-12-11","ACTUAL",{"date":58,"type":56},"2022-12-26",{"date":60,"type":43},"2030-06",{"name":5,"class":6},1]